ZBH
Zimmer Biomet Holdings Inc
NYSE: ZBH · HEALTHCARE · MEDICAL DEVICES
$96.39
+0.34% today
Updated 2026-10-28
Market cap
$18.00B
P/E ratio
22.91
P/S ratio
2.12x
EPS (TTM)
$4.12
Dividend yield
1.05%
52W range
$79 – $106
Volume
1.9M
Zimmer Biomet Holdings Inc (ZBH) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$96.39
12-Month target
$85.98
2030 Target
—
Intrinsic (DCF)
$121.27
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.8B | $6.9B | $7.4B | $7.7B | $8.2B | $8.7B | $9.3B | $9.8B | $10.4B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 6.08% (capped 20%) · P/E: 22.91x (capped 25x) · Margin: 9.48%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.